Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use
CompletedOBSERVATIONAL
Enrollment
172
Participants
Timeline
Start Date
August 4, 2020
Primary Completion Date
December 31, 2021
Study Completion Date
December 31, 2021
Conditions
Relapsed Multiple Myeloma
Trial Locations (1)
72000
Centre Hospitalier Du Mans, Le Mans
All Listed Sponsors
lead
Centre Hospitalier le Mans
OTHER
NCT04811508 - Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use | Biotech Hunter | Biotech Hunter